A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.
Fastest Labs has experienced remarkable growth in number of units since 2018. This rapid expansion demonstrates the strong ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications.
Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...
Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by ...
The Association for Accessible Medicines argued that a California law was trying to regulate business outside state borders.
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
Moleculin Biotech (MBRX) has received FDA feedback and guidance on its IND amendment that has allowed a reduction in the size of its Phase 3 ...
The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback